Feb 20, 2019 - Intercept (ICPT) reports positive top-line results from its pivotal phase III REGENERATE study of OCA in patients with liver fibrosis due to NASH.
Feb 20, 2019 - Growth trumps safety (longevity of raises) in my opinion.Lower current yield is quickly negated over time with high growth.FedEx is one such dividend growth and value play.
Feb 20, 2019 - The stock market is having a great start to the year with the S&P 500 up 11.0% YTD. Finding new companies to put new money to work is getting harder.No matter how high the market soars, something grea
Feb 19, 2019 - Merck & Co Inc (MRK) Chairman, President & CEO Kenneth C Frazier Sold $10.9 million of Shares, Stocks: MRK, release date:Feb 19, 2019
Feb 19, 2019 - AFM13 data at ASH proved deepening and durable for relapsed & refractory Hodgkin's Lymphoma.Data compares favorably to existing salvage therapies and opens the door for accelerated approval.At a R&D d
Feb 19, 2019 - Key brands exceeded sales estimates; Tagrisso and Lynparza are Standards of Care in their respective label indications.The company missed on EPS due to significant operating expenses.Return-to-growth
Feb 19, 2019 - Many dividend growth investors seek the highest-quality companies.Independent data providers such as S&P, Morningstar, and Simply Safe Dividends offer rankings of quality factors.A simple scoring syst
Feb 18, 2019 - Merck's (MRK) sBLA looking for approval of Keytruda plus Pfizer's Inlyta for the first-line treatment of the most common type of kidney cancer gets FDA's priority review.
Feb 14, 2019 - Washington State wants to bring a Netflix model to Hepatitis C care on an RFP model winner-take-all basis.If cost is the major factor here, Gilead could win this contract.By itself, it wouldn't stem t
Feb 14, 2019 - Incyte's (INCY) fourth-quarter earnings miss estimates but revenues beat the same on strong Jakafi sales.